XML 44 R33.htm IDEA: XBRL DOCUMENT
v3.25.3

Net Income (Loss) per Share (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
Schedule of Reconciliation of Weighted Average Shares Outstanding Calculation | The following table provides a reconciliation of the weighted average shares outstanding calculation for the three and nine months ended September 30, 2025 and 2024:
Weighted average number of basic shares outstanding |  |  |  |
| Three months ended September 30, |  | Nine months ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Weighted average shares issued | 35,041,902 |  | 28,000,886 |  | 34,269,244 |  | 26,347,229
Weighted average pre-funded warrants | 1,341,375 |  | 737,421 |  | 1,341,375 |  | 987,983
Weighted average shares outstanding | 36,383,277 |  | 28,738,307 |  | 35,610,619 |  | 27,335,212
Weighted average number of diluted shares outstanding |  |  |  |
| Three months ended September 30, |  | Nine months ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Weighted average shares outstanding (Basic) | 36,383,277 |  | 28,738,307 |  | 35,610,619 |  | 27,335,212
Additional dilutive shares | 3,673,537 |  | 3,607,365 |  |  | 4,339,322 |  |  | — |
Weighted average shares outstanding (Diluted) | 40,056,814 |  | 32,345,672 |  | 39,949,941 |  | 27,335,212
Schedule of Potentially Dilutive Securities Excluded from the Computation of Earnings Per Share | The following potentially dilutive securities were excluded from the computation of earnings per share as of September 30, 2025 and 2024 because their effects would be anti-dilutive:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Common stock warrants | — |  | 3,610,743 |  |  | — |  | 3,627,409
Assumed conversion of preferred stock warrants | — |  | — |  |  | — |  | 4,108,328
Assumed conversion of preferred stock | — |  | — |  |  | — |  | 1,454,509
Assumed conversion of convertible notes | — |  | 237,614 |  |  | — |  | 237,614
Stock options | 3,510,565 |  | 1,489,310 |  |  | 3,510,565 |  | 6,055,728
Assumed conversion of ESPP | 42,570 |  | 35,512 |  | 42,570 |  | 35,512
Total | 3,553,135 |  | 5,373,179 |  | 3,553,135 |  | 15,519,100

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration